Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

FDA Proposed Updates: Drug Establishment Registration & Drug Listing for Distributed Manufacturing and Foreign Facilities

$129.99

Stay ahead of regulatory changes with this specialized course on the FDA’s proposed amendments to drug establishment registration and listing. Designed for pharmaceutical professionals and regulatory teams, this course breaks down new pathways for registering distributed manufacturing establishments (DMEs) and clarifies requirements for foreign drug facilities under the PREVENT Pandemics Act. Learn how the hub-and-spoke model affects compliance, what’s required for supply chain visibility, and how to effectively prepare for implementation. Gain actionable insight on timely submissions, required information, and potential impacts on your business.

In this course you will learn the following:
* Explain the goals and rationale behind the proposed rule.
* Identify the new registration and listing requirements for distributed manufacturing establishments (DMEs) and foreign establishments.
* Understand the hub-and-spoke model of distributed manufacturing and its regulatory implications.
* Recognize the opportunities for public comment and the importance of stakeholder engagement.
* Anticipate how the proposed rule may evolve before finalization.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Why This Course is Important
Without this course, your organization risks non-compliance with upcoming FDA requirements, leading to potential product misbranding, regulatory delays, and restricted access to the U.S. drug market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments.

Key regulatory references include:

Course SKU
FR-26-2077-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

FDA Proposed Updates: Drug Establishment Registration & Drug Listing for Distributed Manufacturing and Foreign Facilities

Stay ahead of regulatory changes with this specialized course on the FDA’s proposed amendments to drug establishment registration and listing. Designed for pharmaceutical professionals and regulatory teams, this course breaks down new pathways for registering distributed manufacturing establishments (DMEs) and clarifies requirements for foreign drug facilities under the PREVENT Pandemics Act. Learn how the hub-and-spoke model affects compliance, what’s required for supply chain visibility, and how to effectively prepare for implementation. Gain actionable insight on timely submissions, required information, and potential impacts on your business.

In this course you will learn the following:
* Explain the goals and rationale behind the proposed rule.
* Identify the new registration and listing requirements for distributed manufacturing establishments (DMEs) and foreign establishments.
* Understand the hub-and-spoke model of distributed manufacturing and its regulatory implications.
* Recognize the opportunities for public comment and the importance of stakeholder engagement.
* Anticipate how the proposed rule may evolve before finalization.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Why This Course is Important
Without this course, your organization risks non-compliance with upcoming FDA requirements, leading to potential product misbranding, regulatory delays, and restricted access to the U.S. drug market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments.

Key regulatory references include:

Course SKU
FR-26-2077-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

FDA Proposed Updates: Drug Establishment Registration & Drug Listing for Distributed Manufacturing and Foreign Facilities

$129.99

Why This Course is Important
Without this course, your organization risks non-compliance with upcoming FDA requirements, leading to potential product misbranding, regulatory delays, and restricted access to the U.S. drug market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments.

Key regulatory references include:

Course SKU
FR-26-2077-1

Stay ahead of regulatory changes with this specialized course on the FDA’s proposed amendments to drug establishment registration and listing. Designed for pharmaceutical professionals and regulatory teams, this course breaks down new pathways for registering distributed manufacturing establishments (DMEs) and clarifies requirements for foreign drug facilities under the PREVENT Pandemics Act. Learn how the hub-and-spoke model affects compliance, what’s required for supply chain visibility, and how to effectively prepare for implementation. Gain actionable insight on timely submissions, required information, and potential impacts on your business.

In this course you will learn the following:
* Explain the goals and rationale behind the proposed rule.
* Identify the new registration and listing requirements for distributed manufacturing establishments (DMEs) and foreign establishments.
* Understand the hub-and-spoke model of distributed manufacturing and its regulatory implications.
* Recognize the opportunities for public comment and the importance of stakeholder engagement.
* Anticipate how the proposed rule may evolve before finalization.

Related products